← Open Payments lookup

GAVIN GIST: Open Payments

NPI 1952574048 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$910 in 27 payments from 11 companies in 2025. Trend: 2023 $3,656 · 2024 $1,272 · 2025 $910

Food & beverage: $910
CompanyPaymentsAmount
Edwards Lifesciences Corporation1$200
AstraZeneca Pharmaceuticals LP7$190
Merck Sharp & Dohme LLC6$123
E.R. Squibb & Sons, L.L.C.1$98
Alnylam Pharmaceuticals Inc.1$94
Boehringer Ingelheim Pharmaceuticals, Inc.3$59
Bayer Healthcare Pharmaceuticals Inc.2$38
PFIZER INC.2$37
Amgen Inc.2$36
Esperion Therapeutics, Inc.1$21

Products named: WAINUA, VERQUVO, CAMZYOS, AMVUTTRA, LOKELMA, JARDIANCE, Kerendia, VYNDAQEL.

Industry payments across MS — which companies pay providers there.